Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2002 May 15;364(Pt 1):41–47. doi: 10.1042/bj3640041

Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells.

Maria Ruzzene 1, Daniele Penzo 1, Lorenzo A Pinna 1
PMCID: PMC1222543  PMID: 11988074

Abstract

Incubation of Jurkat cells with 4,5,6,7-tetrabromobenzotriazole (TBB), a specific inhibitor of protein kinase CK2, induces dose-and time-dependent apoptosis as judged by several criteria. TBB-promoted apoptosis is preceded by inhibition of Ser/Thr phosphorylation of haematopoietic lineage cell-specific protein 1 (HS1) and is accompanied by caspase-dependent fragmentation of the same protein. Both effects are also observable if apoptosis is promoted by anti-Fas antibodies and by etoposide. Moreover, in vitro experiments show that HS1, once phosphorylated by CK2, becomes refractory to cleavage by caspase-3. These findings, in conjunction with similar data in the literature concerning two other CK2 protein substrates, Bid and Max, suggest that CK2 may play a general anti-apoptotic role through the generation of phosphorylated sites conferring resistance to caspase cleavage.

Full Text

The Full Text of this article is available as a PDF (180.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benhamou L. E., Watanabe T., Kitamura D., Cazenave P. A., Sarthou P. Signaling properties of anti-immunoglobulin--resistant variants of WEHI-231 B lymphoma cells. Eur J Immunol. 1994 Sep;24(9):1993–1999. doi: 10.1002/eji.1830240909. [DOI] [PubMed] [Google Scholar]
  2. Berndt N. Protein dephosphorylation and the intracellular control of the cell number. Front Biosci. 1999 Jan 1;4:D22–D42. doi: 10.2741/berndt. [DOI] [PubMed] [Google Scholar]
  3. Brunati A. M., Donella-Deana A., James P., Quadroni M., Contri A., Marin O., Pinna L. A. Molecular features underlying the sequential phosphorylation of HS1 protein and its association with c-Fgr protein-tyrosine kinase. J Biol Chem. 1999 Mar 12;274(11):7557–7564. doi: 10.1074/jbc.274.11.7557. [DOI] [PubMed] [Google Scholar]
  4. Brunati A. M., Ruzzene M., James P., Guerra B., Pinna L. A. Hierarchical phosphorylation of a 50-kDa protein by protein tyrosine kinases TPK-IIB and C-Fgr, and its identification as HS1 hematopoietic-lineage cell-specific protein. Eur J Biochem. 1995 Apr 1;229(1):164–170. doi: 10.1111/j.1432-1033.1995.tb20451.x. [DOI] [PubMed] [Google Scholar]
  5. Desagher S., Osen-Sand A., Montessuit S., Magnenat E., Vilbois F., Hochmann A., Journot L., Antonsson B., Martinou J. C. Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. Mol Cell. 2001 Sep;8(3):601–611. doi: 10.1016/s1097-2765(01)00335-5. [DOI] [PubMed] [Google Scholar]
  6. Faust R. A., Tawfic S., Davis A. T., Bubash L. A., Ahmed K. Antisense oligonucleotides against protein kinase CK2-alpha inhibit growth of squamous cell carcinoma of the head and neck in vitro. Head Neck. 2000 Jul;22(4):341–346. doi: 10.1002/1097-0347(200007)22:4<341::aid-hed5>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  7. Fukuda T., Kitamura D., Taniuchi I., Maekawa Y., Benhamou L. E., Sarthou P., Watanabe T. Restoration of surface IgM-mediated apoptosis in an anti-IgM-resistant variant of WEHI-231 lymphoma cells by HS1, a protein-tyrosine kinase substrate. Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7302–7306. doi: 10.1073/pnas.92.16.7302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Grankowski N., Boldyreff B., Issinger O. G. Isolation and characterization of recombinant human casein kinase II subunits alpha and beta from bacteria. Eur J Biochem. 1991 May 23;198(1):25–30. doi: 10.1111/j.1432-1033.1991.tb15982.x. [DOI] [PubMed] [Google Scholar]
  9. Guerra B., Boldyreff B., Issinger O. G. FAS-associated factor 1 interacts with protein kinase CK2 in vivo upon apoptosis induction. Int J Oncol. 2001 Dec;19(6):1117–1126. doi: 10.3892/ijo.19.6.1117. [DOI] [PubMed] [Google Scholar]
  10. Guerra B., Issinger O. G. Protein kinase CK2 and its role in cellular proliferation, development and pathology. Electrophoresis. 1999 Feb;20(2):391–408. doi: 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
  11. Guo C., Yu S., Davis A. T., Wang H., Green J. E., Ahmed K. A potential role of nuclear matrix-associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells. J Biol Chem. 2000 Nov 7;276(8):5992–5999. doi: 10.1074/jbc.M004862200. [DOI] [PubMed] [Google Scholar]
  12. Hata D., Nakamura T., Kawakami T., Kawakami Y., Herren B., Mayumi M. Tyrosine phosphorylation of MB-1, B29, and HS1 proteins in human B cells following receptor crosslinking. Immunol Lett. 1994 Apr;40(1):65–71. doi: 10.1016/0165-2478(94)90208-9. [DOI] [PubMed] [Google Scholar]
  13. Kelliher M. A., Seldin D. C., Leder P. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. EMBO J. 1996 Oct 1;15(19):5160–5166. [PMC free article] [PubMed] [Google Scholar]
  14. Kitamura D., Kaneko H., Miyagoe Y., Ariyasu T., Watanabe T. Isolation and characterization of a novel human gene expressed specifically in the cells of hematopoietic lineage. Nucleic Acids Res. 1989 Nov 25;17(22):9367–9379. [PMC free article] [PubMed] [Google Scholar]
  15. Krippner-Heidenreich A., Talanian R. V., Sekul R., Kraft R., Thole H., Ottleben H., Lüscher B. Targeting of the transcription factor Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1. Biochem J. 2001 Sep 15;358(Pt 3):705–715. doi: 10.1042/0264-6021:3580705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Landesman-Bollag E., Channavajhala P. L., Cardiff R. D., Seldin D. C. p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice. Oncogene. 1998 Jun 11;16(23):2965–2974. doi: 10.1038/sj.onc.1201854. [DOI] [PubMed] [Google Scholar]
  17. Li D., Dobrowolska G., Aicher L. D., Chen M., Wright J. H., Drueckes P., Dunphy E. L., Munar E. S., Krebs E. G. Expression of the casein kinase 2 subunits in Chinese hamster ovary and 3T3 L1 cells provides information on the role of the enzyme in cell proliferation and the cell cycle. J Biol Chem. 1999 Nov 12;274(46):32988–32996. doi: 10.1074/jbc.274.46.32988. [DOI] [PubMed] [Google Scholar]
  18. Marin O., Meggio F., Pinna L. A. Design and synthesis of two new peptide substrates for the specific and sensitive monitoring of casein kinases-1 and -2. Biochem Biophys Res Commun. 1994 Feb 15;198(3):898–905. doi: 10.1006/bbrc.1994.1128. [DOI] [PubMed] [Google Scholar]
  19. Martin A. G., Fresno M. Tumor necrosis factor-alpha activation of NF-kappa B requires the phosphorylation of Ser-471 in the transactivation domain of c-Rel. J Biol Chem. 2000 Aug 11;275(32):24383–24391. doi: 10.1074/jbc.M909396199. [DOI] [PubMed] [Google Scholar]
  20. Meggio F., Marin O., Pinna L. A. Substrate specificity of protein kinase CK2. Cell Mol Biol Res. 1994;40(5-6):401–409. [PubMed] [Google Scholar]
  21. Orlandini M., Semplici F., Ferruzzi R., Meggio F., Pinna L. A., Oliviero S. Protein kinase CK2alpha' is induced by serum as a delayed early gene and cooperates with Ha-ras in fibroblast transformation. J Biol Chem. 1998 Aug 14;273(33):21291–21297. doi: 10.1074/jbc.273.33.21291. [DOI] [PubMed] [Google Scholar]
  22. Padmanabha R., Chen-Wu J. L., Hanna D. E., Glover C. V. Isolation, sequencing, and disruption of the yeast CKA2 gene: casein kinase II is essential for viability in Saccharomyces cerevisiae. Mol Cell Biol. 1990 Aug;10(8):4089–4099. doi: 10.1128/mcb.10.8.4089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pinna L. A. Casein kinase 2: an 'eminence grise' in cellular regulation? Biochim Biophys Acta. 1990 Sep 24;1054(3):267–284. doi: 10.1016/0167-4889(90)90098-x. [DOI] [PubMed] [Google Scholar]
  24. Pinna L. A., Meggio F. Protein kinase CK2 ("casein kinase-2") and its implication in cell division and proliferation. Prog Cell Cycle Res. 1997;3:77–97. doi: 10.1007/978-1-4615-5371-7_7. [DOI] [PubMed] [Google Scholar]
  25. Robertson J. D., Gogvadze V., Zhivotovsky B., Orrenius S. Distinct pathways for stimulation of cytochrome c release by etoposide. J Biol Chem. 2000 Oct 20;275(42):32438–32443. doi: 10.1074/jbc.C000518200. [DOI] [PubMed] [Google Scholar]
  26. Ruzzene M., Brunati A. M., Marin O., Donella-Deana A., Pinna L. A. SH2 domains mediate the sequential phosphorylation of HS1 protein by p72syk and Src-related protein tyrosine kinases. Biochemistry. 1996 Apr 23;35(16):5327–5332. doi: 10.1021/bi9528614. [DOI] [PubMed] [Google Scholar]
  27. Ruzzene M., Brunati A. M., Sarno S., Marin O., Donella-Deana A., Pinna L. A. Ser/Thr phosphorylation of hematopoietic specific protein 1 (HS1): implication of protein kinase CK2. Eur J Biochem. 2000 May;267(10):3065–3072. doi: 10.1046/j.1432-1033.2000.01333.x. [DOI] [PubMed] [Google Scholar]
  28. Sarno S., Reddy H., Meggio F., Ruzzene M., Davies S. P., Donella-Deana A., Shugar D., Pinna L. A. Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2'). FEBS Lett. 2001 May 4;496(1):44–48. doi: 10.1016/s0014-5793(01)02404-8. [DOI] [PubMed] [Google Scholar]
  29. Sarno S., Vaglio P., Meggio F., Issinger O. G., Pinna L. A. Protein kinase CK2 mutants defective in substrate recognition. Purification and kinetic analysis. J Biol Chem. 1996 May 3;271(18):10595–10601. doi: 10.1074/jbc.271.18.10595. [DOI] [PubMed] [Google Scholar]
  30. Sayed M., Pelech S., Wong C., Marotta A., Salh B. Protein kinase CK2 is involved in G2 arrest and apoptosis following spindle damage in epithelial cells. Oncogene. 2001 Oct 25;20(48):6994–7005. doi: 10.1038/sj.onc.1204894. [DOI] [PubMed] [Google Scholar]
  31. Seldin D. C., Leder P. Casein kinase II alpha transgene-induced murine lymphoma: relation to theileriosis in cattle. Science. 1995 Feb 10;267(5199):894–897. doi: 10.1126/science.7846532. [DOI] [PubMed] [Google Scholar]
  32. Szyszka R., Grankowski N., Felczak K., Shugar D. Halogenated benzimidazoles and benzotriazoles as selective inhibitors of protein kinases CK I and CK II from Saccharomyces cerevisiae and other sources. Biochem Biophys Res Commun. 1995 Mar 8;208(1):418–424. doi: 10.1006/bbrc.1995.1354. [DOI] [PubMed] [Google Scholar]
  33. Taniuchi I., Kitamura D., Maekawa Y., Fukuda T., Kishi H., Watanabe T. Antigen-receptor induced clonal expansion and deletion of lymphocytes are impaired in mice lacking HS1 protein, a substrate of the antigen-receptor-coupled tyrosine kinases. EMBO J. 1995 Aug 1;14(15):3664–3678. doi: 10.1002/j.1460-2075.1995.tb00036.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Tawfic S., Yu S., Wang H., Faust R., Davis A., Ahmed K. Protein kinase CK2 signal in neoplasia. Histol Histopathol. 2001 Apr;16(2):573–582. doi: 10.14670/HH-16.573. [DOI] [PubMed] [Google Scholar]
  35. Thornberry N. A., Chapman K. T., Nicholson D. W. Determination of caspase specificities using a peptide combinatorial library. Methods Enzymol. 2000;322:100–110. doi: 10.1016/s0076-6879(00)22011-9. [DOI] [PubMed] [Google Scholar]
  36. Yamanashi Y., Fukuda T., Nishizumi H., Inazu T., Higashi K., Kitamura D., Ishida T., Yamamura H., Watanabe T., Yamamoto T. Role of tyrosine phosphorylation of HS1 in B cell antigen receptor-mediated apoptosis. J Exp Med. 1997 Apr 7;185(7):1387–1392. doi: 10.1084/jem.185.7.1387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Yamanashi Y., Okada M., Semba T., Yamori T., Umemori H., Tsunasawa S., Toyoshima K., Kitamura D., Watanabe T., Yamamoto T. Identification of HS1 protein as a major substrate of protein-tyrosine kinase(s) upon B-cell antigen receptor-mediated signaling. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3631–3635. doi: 10.1073/pnas.90.8.3631. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES